drugset / Trial / NCT03353012

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

NCT03353012

Phase 4 Completed 60 enrolled Chulalongkorn University
RandomizedParallel-groupOpen-labelTreatment

Summary

To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.

Timeline

Start
2018-01-01
Primary completion
2018-05-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown 68 mg Other
Subject Levonorgestrel Small molecule 75 mg Other

Indications